Novozymes A S DKK 2.0

13F holders, Q3 2024 (September 30)
5holders
0new positions
0sold out
$71.85avg. 13F price*

At the end of Q3 2024, 5 institutions reported holding Novozymes A S DKK 2.0 in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Somerville Kurt F ($1.5M), Hemenway Trust Co LLC ($354K) and Puzo Michael J ($302K).

Company
Novozymes A S DKK 2.0
CUSIP
B798FW902
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 5Q1 2024Q2 2024: 5Q2 2024Q3 2024: 5Q3 2024Q4 2024: 3Q4 2024Q1 2025: 2Q1 2025Q2 2025: 3Q2 2025Q3 2025: 2Q3 2025Q4 2025: 3Q4 2025Q1 2026: 3Q1 2026Q2 2026: 4Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q2 2024 → Q3 2024: 16,075 shares sold, net −16,075 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 5 holders

Somerville Kurt F 0.25% Reduce -6.3% 21,390 $1.5M
Hemenway Trust Co LLC 0.03% Reduce -10.9% 4,921 $354K
Puzo Michael J 0.08% Reduce -12.0% 4,200 $302K
Kidder Stephen W 0.09% Reduce -43.9% 4,025 $289K
Broderick Brian C 0.05% Reduce -76.3% 3,209 $231K

"% of holder's portfolio" is NOVOZYMES A S DKK 2.0's weight in each manager's 13F, not the share of Novozymes A S DKK 2.0 the manager owns.